BetterLife Pharma Inc. (BETRF)
OTCMKTS · Delayed Price · Currency is USD
0.2300
-0.0700 (-23.33%)
Aug 10, 2026, 3:12 PM EST
BetterLife Pharma Company Description
BetterLife Pharma Inc., a biotechnology company, engages in the development of psychedelic-derived compounds.
It focuses on developing and commercializing BETR-001, a non-hallucinogenic and non-controlled LSD derivative to treat neuro-psychiatric and neurological disorders.
Its products also comprise MM-001, a topical cream for local intravaginal use to treat HPV-induced cervical intraepithelial neoplasia; and MM-003, a patent pending proprietary interferon alpha-2b inhalation formulation.
The company was formerly known as Pivot Pharmaceuticals Inc. and changed its name to BetterLife Pharma Inc. in December 2019.
BetterLife Pharma Inc. was incorporated in 2002 and is headquartered in Vancouver, Canada.
BetterLife Pharma Inc.
| Country | Canada |
| Founded | 2002 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 7 |
| CEO | Ahmad Doroudian |
Contact Details
Address: 1275 West 6th Avenue Vancouver, BC V6H 1A6 Canada | |
| Website | abetterlifepharma.com |
Stock Details
| Ticker Symbol | BETRF |
| Exchange | OTCMKTS |
| Stock Type | Common Stock |
| Fiscal Year | February - January |
| Reporting Currency | CAD |
| ISIN Number | CA08772P2026 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Dr. Ahmad Doroudian Ph.D. | Founder, Chief Executive Officer and Director |
| Moira Ong C.A., CPA, CFA | Chief Financial Officer |
| Dr. Hooshmand Sheshbaradaran Ph.D. | Chief Operating Officer |
| Dr. Stephen Sangha | Corporate Development Advisor and Director |
| Douglas L. Drysdale | Executive Chairman and Member of Scientific Advisory Board |
| Scott Rudge Ph.D. | Head of CMC |